Get started
INCYTE CORPORATIONINCYTE CORPORATIONINCYTE CORPORATION

INCYTE CORPORATION

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

ICY chart


Full chart

ICY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.84 B‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
449.671
Basic EPS (TTM)
0.141 CHF
Net income (FY)
‪503.14 M‬ CHF
Revenue (FY)
‪3.11 B‬ CHF
Shares float
‪190.30 M‬
Beta (1Y)
0.75

Employees


Employees (FY)
‪2.52 K‬
Change (1Y)
+200 +8.61%
Revenue / Employee (1Y)
‪1.46 M‬ CHF
Net income / Employee (1Y)
‪236.77 K‬ CHF

About Incyte Corporation


Sector
Health Technology
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
incyte.com
Founded
1991
FIGI
BBG00LVDL5R6
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ICY news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where ICY is featured.

See all sparks 

Frequently Asked Questions


The current price of ICY is 70.686 CHF — it has increased by 27.09% in the past 24 hours. Watch INCYTE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange INCYTE CORPORATION stocks are traded under the ticker ICY.
ICY stock has risen by 27.09% compared to the previous week, the month change is a 27.09% rise, over the last year INCYTE CORPORATION has showed a 4.56% increase.
We've gathered analysts' opinions on INCYTE CORPORATION future price: according to them, ICY price has a max estimate of 84.08 CHF and a min estimate of 45.08 CHF. Watch ICY chart and read a more detailed INCYTE CORPORATION stock forecast: see what analysts think of INCYTE CORPORATION and suggest that you do with its stocks.
ICY reached its all-time high on Nov 8, 2024 with the price of 70.686 CHF, and its all-time low was 55.618 CHF and was reached on Dec 14, 2023. View more price dynamics on ICY chart.
See other stocks reaching their highest and lowest prices.
ICY stock is 21.32% volatile and has beta coefficient of 0.75. Track INCYTE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is INCYTE CORPORATION there?
Today INCYTE CORPORATION has the market capitalization of ‪13.84 B‬, it has increased by 9.72% over the last week.
Yes, you can track INCYTE CORPORATION financials in yearly and quarterly reports right on TradingView.
INCYTE CORPORATION is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ICY earnings for the last quarter are 0.91 CHF per share, whereas the estimation was 0.89 CHF resulting in a 1.79% surprise. The estimated earnings for the next quarter are 1.32 CHF per share. See more details about INCYTE CORPORATION earnings.
INCYTE CORPORATION revenue for the last quarter amounts to ‪964.26 M‬ CHF, despite the estimated figure of ‪913.77 M‬ CHF. In the next quarter, revenue is expected to reach ‪1.00 B‬ CHF.
ICY net income for the last quarter is ‪90.21 M‬ CHF, while the quarter before that showed ‪−399.71 M‬ CHF of net income which accounts for 122.57% change. Track more INCYTE CORPORATION financial stats to get the full picture.
No, ICY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 12, 2024, the company has ‪2.52 K‬ employees. See our rating of the largest employees — is INCYTE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE CORPORATION EBITDA is ‪64.56 M‬ CHF, and current EBITDA margin is 19.87%. See more stats in INCYTE CORPORATION financial statements.
Like other stocks, ICY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.